Perspectives of nanoemulsion assisted oral delivery of docetaxel for improved chemotherapy of cancer

Drug Delivery

Volumn 23, Issue 2, 2016, Pages 479-488

  Verma, Prerna ^a,b   Meher, Jaya Gopal ^a   Asthana, Shalini ^a   Pawar, Vivek K ^a   Chaurasia, Mohini ^b   Chourasia, Manish K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b AMITY UNIVERSITY   (India)

Author keywords

Acute toxicity; droplet size; MTT assay; soybean oil; zeta potential

Indexed keywords

ALCOHOL; DOCETAXEL; MACROGOL 400; MACROGOL 4000; NANOCARRIER; PHOSPHATIDYLCHOLINE; PLACEBO; POLOXAMER; SOYBEAN OIL; ANTINEOPLASTIC AGENT; DRUG CARRIER; EMULSION; EXCIPIENT; MACROGOL DERIVATIVE; NANOPARTICLE; SURFACTANT; TAXOID;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CELL DEATH; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGRADATION; DISPERSION; DRUG ABSORPTION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG SOLUBILITY; FEMALE; HUMAN; HUMAN CELL; HYDROPHILICITY; IC50; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MCF 7 CELL LINE; MOLECULAR STABILITY; MOUSE; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; STORAGE; SUSTAINED DRUG RELEASE; THERMODYNAMICS; THERMOSTABILITY; ZETA POTENTIAL; ANIMAL; BREAST NEOPLASMS; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG STABILITY; EMULSION; HEAT; MCF-7 CELL LINE; METABOLISM; NANOTECHNOLOGY; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHARMACEUTICS; PROCEDURES; SOLUBILITY; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASOUND;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; EMULSIONS; ETHANOL; EXCIPIENTS; FEMALE; HOT TEMPERATURE; HUMANS; INHIBITORY CONCENTRATION 50; LECITHINS; MCF-7 CELLS; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; POLOXAMER; POLYETHYLENE GLYCOLS; SOLUBILITY; SOYBEAN OIL; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS; TAXOIDS; TECHNOLOGY, PHARMACEUTICAL; ULTRASONICS;

EID: 84954349069     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2014.920430     Document Type: Article

References (49)

1. Asthana S, Jaiswal AK, Gupta PK, et al. (2013). Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules. Antimicrob Agents Chemother 57: 1714-22
2. Bae WK, Park MS, Lee JH, et al. (2013). Docetaxel-loaded thermoresponsive conjugated linoleic acid-incorporated poloxamer hydrogel for the suppression of peritoneal metastasis of gastric cancer. Biomaterials 34: 1433-41
3. Beer C, Foldbjerg R, Hayashi Y, et al. (2012). Toxicity of silver nanoparticles-nanoparticle or silver ion? Toxicol Lett 208: 286-92
4. Bilbao-Sainz C, Avena-Bustillos RJ, Wood DF, et al. (2010). Nanoemulsions prepared by a low-energy emulsification method applied to edible films. J Agric Food Chem 58: 11932-8
5. Borhade V, Pathak S, Sharma S, Patravale V. (2012). Clotrimazole nanoemulsion for malaria chemotherapy. Part II: Stability assessment, in vivo pharmacodynamic evaluations and toxicological studies. Int J Pharm 431: 149-60
6. Brusewitz C, Schendler A, Funke A, et al. (2007). Novel poloxamer-based nanoemulsions to enhance the intestinal absorption of active compounds. Int J Pharm 329: 173-81
7. Chaurasia M, Chourasia M, Jain NK, et al. (2008). Methotrexate bearing calcium pectinate microspheres: a platform to achieve colon-specific drug release. Curr Drug Deliv 5: 215-19
8. Cheng J, Teply BA, Sherifi I, et al. (2007). Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 28: 869-76
9. Cho H-J, Yoon HY, Koo H, et al. (2011). Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel. Biomaterials 32: 7181-90
10. Choudhury H, Gorain B, Karmakar S, et al. (2014). Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform. Int J Pharma 460: 131-43
11. Chourasia MK, Kang L, Chan SY. (2011). Nanosized ethosomes bearing ketoprofen for improved transdermal delivery. Results Pharma Sci 1: 60-67
12. Dasgupta S, Dey S, Choudhury S, Mazumder B. (2013). Topical delivery of aceclofenac as nanoemulsion comprising excipients having optimum emulsification capabilities: preparation, characterization and in vivo evaluation. Expert Opin Drug Deliv 10: 411-20
13. Díaz C, Vargas E, Gätjens-Boniche O. (2006). Cytotoxic effect induced by retinoic acid loaded into galactosyl-sphingosine containing liposomes on human hepatoma cell lines. Int J Pharm 325: 108-15
14. El-Readi MZ, Hamdan D, Farrag N, et al. (2010). Inhibition of P-glycoprotein activity by limonin and other secondary metabolites from Citrus species in human colon and leukaemia cell lines. Eur J Pharmacol 626: 139-45
15. Eytan GD, Kuchel PW. (1999). Mechanism of action of p-glycoprotein in relation to passive membrane permeation. In: Kwang WJ. (ed.) International review of cytology. Academic Press. 175-250
16. Ganesh T. (2007). Improved biochemical strategies for targeted delivery of taxoids. Bioorg Med Chem Lett 15: 3597-623
17. Gao K, Sun J, Liu K, et al. (2008). Preparation and characterization of a submicron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel. Drug Dev Ind Pharm 34: 1227-37
18. Gupta Y, Soni V, Chourasia M, et al. (2005). Targeted drug delivery to the brain via transferrin coupled liposomes. Drug Deliv Tech 5: 66-71
19. He W, Lu Y, Qi J, et al. (2013). Nanoemulsion-templated shell-crosslinked nanocapsules as drug delivery systems. Int J Pharma 445: 69-78
20. He W, Tan Y, Tian Z, et al. (2011). Food protein-stabilized nanoemulsions as potential delivery systems for poorly water-soluble drugs: preparation, in vitro characterization, and pharmacokinetics in rats. Int J Nanomedicine 6: 521-33
21. Hosny KM, Banjar ZM. (2013). The formulation of a nasal nanoemulsion zaleplon in situ gel for the treatment of insomnia. Expert Opin Drug Deliv 10: 1033-41
22. Hu X, Tulsieram KL, Zhou Q, et al. (2012). Polymeric nanoparticle-aptamer bioconjugates can diminish the toxicity of mercury in vivo. Toxicol Lett 208: 69-74
23. Jain S, Chourasia M, Dengre R. (2005). Azo polymers for colon targeted drug delivery. Indian J Pharma Sci 67: 43-50
24. Jiang SP, He SN, Li YL, et al. (2013). Preparation and characteristics of lipid nanoemulsion formulations loaded with doxorubicin. Int J Nanomedicine 8: 3141-50
25. Jinturkar KA, Anish C, Kumar MK, et al. (2012). Liposomal formulations of etoposide and docetaxel for p53 mediated enhanced cytotoxicity in lung cancer cell lines. Biomaterials 33: 2492-507
26. Kong M, Park HJ. (2011). Stability investigation of hyaluronic acid based nanoemulsion and its potential as transdermal carrier. Carbohyd Polym 83: 1303-10
27. Lee E, Kim H, Lee I-H, Jon S. (2009). In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration. J Controlled Release 140: 79-85
28. Liu B, Yang M, Li R, et al. (2008). The antitumor effect of novel docetaxel-loaded thermosensitive micelles. Eur J Pharm Biopharm 69: 527-34
29. Liu D, Liu Z, Wang L, et al. (2011). Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf B Biointerface 85: 262-9
30. Manjappa AS, Goel PN, Vekataraju MP, et al. (2013). Is an alternative drug delivery system needed for docetaxel? The role of controlling epimerization in formulations and beyond. Pharm Res 30: 2675-93
31. Meher JG, Yadav NP, Sahu JJ, Sinha P. (2013). Determination of required hydrophilic-lipophilic balance of citronella oil and development of stable cream formulation. Drug Dev Ind Pharm 39: 1540-6
32. Mishra N, Yadav NP, Meher JG, Sinha P. (2012). Phyto-vesicles: conduit between conventional and novel drug delivery system. Asian Pac J Trop Biomed 2: S1728-34
33. Moes JJ, Koolen SLW, Huitema ADR, et al. (2011). Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001). Int J Pharma 420: 244-50
34. Muller RH, Harden D, Keck CM. (2012). Development of industrially feasible concentrated 30% and 40% nanoemulsions for intravenous drug delivery. Drug Dev Ind Pharm 38: 420-30
35. Oh DH, Balakrishnan P, Oh Y-K, et al. (2011). Effect of process parameters on nanoemulsion droplet size and distribution in SPG membrane emulsification. Int J Pharma 404: 191-7
36. Peng L-C, Liu C-H, Kwan C-C, Huang K-F. (2010). Optimization of water-in-oil nanoemulsions by mixed surfactants. Colloids Surf A Physicochem Eng Asp 370: 136-42
37. Qiu Y, Gao Y, Hu K, Li F. (2008). Enhancement of skin permeation of docetaxel: A novel approach combining microneedle and elastic liposomes. J Controlled Release 129: 144-50
38. Rahn-Chique K, Puertas AM, Romero-Cano MS, et al. (2012). Nanoemulsion stability: Experimental evaluation of the flocculation rate from turbidity measurements. Adv Colloid Interface Sci 178: 1-20
39. Saito H, Tanaka M, Okamura E, et al. (2001). Interactions of phosphatidylcholine surface monolayers with triglyceride cores and enhanced apoa-1 binding in lipid emulsions. Langmuir 17: 2528-32
40. Sakulku U, Nuchuchua O, Uawongyart N, et al. (2009). Characterization and mosquito repellent activity of citronella oil nanoemulsion. Int J Pharma 372: 105-11
41. Seo YG, Kim DH, Ramasamy T, et al. (2013). Development of docetaxel-loaded solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced chemotherapeutic effect. Int J Pharma 452: 412-20
42. Singh S, Junwal M, Modhe G, et al. (2013). Forced degradation studies to assess the stability of drugs and products. Trends Anal Chem 49: 71-88
43. Spratlin J, Sawyer MB. (2007). Pharmacogenetics of paclitaxel metabolism. Crit Rev Oncol Hematol 61: 222-9
44. Sweetman S. (2007). Martindale: the complete drug reference. London: The Pharmaceutical Press
45. Tanaka M, Saito H, Arimoto I, et al. (2003). Evidence for interpenetration of core triglycerides into surface phospholipid monolayers in lipid emulsions. Langmuir 19: 5192-6
46. Tang SY, Sivakumar M, Ng AM-H, Shridharan P. (2012). Anti-inflammatory and analgesic activity of novel oral aspirin-loaded nanoemulsion and nano multiple emulsion formulations generated using ultrasound cavitation. Int J Pharma 430: 299-306
47. Undevia SD, Gomez-Abuin G, Ratain MJ. (2005). Pharmacokinetic variability of anticancer agents. Nat Rev Cancer 5: 447-58
48. Yadav NP, Meher JG, Pandey N, et al. (2013). Enrichment, Development, and Assessment of Indian Basil Oil Based Antiseptic Cream Formulation Utilizing Hydrophilic-Lipophilic Balance Approach, Biomed Res Int 2013: 410686, doi: 10.1155/2013/410686
49. Yin Y-M, Cui F-D, Mu C-F, et al. (2009). Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation. J Controlled Release 140: 86-94